本頁面由Tiger Trade Technology Pte. Ltd.提供服務

IO Biotech, Inc.

0.8654
+0.05546.84%
成交量:45.12萬
成交額:38.49萬
市值:6,226.45萬
市盈率:-0.65
高:0.8800
開:0.8046
低:0.8010
收:0.8100
52周最高:2.79
52周最低:0.3234
股本:7,194.88萬
流通股本:3,116.00萬
量比:0.55
換手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-1.3356
每股收益(LYR):-1.4494
淨資產收益率:-240.48%
總資產收益率:-88.58%
市淨率:68.35
市盈率(LYR):-0.60

資料載入中...

2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/19

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/09/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/06

SEC問詢函

Form CORRESP - Correspondence
2023/08/17

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/16

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]